Unblind the Niraparib NOVA study for Ahava Emuna Lange

This petition made change with 3,372 supporters!

Niraparib NOVA Study Breach of Contract

Ahava Emuna Lange has been in the Niraparib study for 10 months and is now having her 2nd recurrence of ovarian cancer. The Niraparib Tesaro group is refusing to unblind the study and tell Mrs. Lange and her physician what she was taking. This is a breach of the contract, which clearly states that if medically necessary TESARO are legally bound to inform her doctors whether your drug company was giving her placebo or PARPs.

She cannot get into any other drug trials or receive the FDA approved PARPs inhibitor, Olaparib, unless there is proof from Tesaro that she was on a placebo. It would be a waste of her time (and life) to give her PARPs again if the Niraparib didn't work.

TESARO have proven themselves to be unreliable and unethical - grounds for litigation and possible closing down of the entire Niraparib drug trial.

TESARO's representatives admitted (on the phone to Mrs. Lange's oncologist) that they are in breach of contract and know that TESARO will lose the case brought against them.

Mrs. Lange's life hangs in danger. The treatment she's receiving by TESARO is cruel, insensitive and inhumane.

Please make sure that your company does the right thing. Your doctors need to provide Mrs. Lange's team of oncologists with the information as promised both in many phone calls and in writing in e-mail correspondence with the Shaare Zedek Medical Center.


Today: Nita is counting on you

Nita Kurrant needs your help with “Tesaro: Unblind the Niraparib NOVA study for Ahava Emuna Lange”. Join Nita and 3,371 supporters today.